Pathstone Family Office’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $9.87M | Buy |
141,150
+26,602
| +23% | +$1.88M | 0.08% | 174 |
|
|
2023
Q2 | $7.83M | Buy |
114,548
+6,466
| +6% | +$460K | 0.11% | 124 |
|
|
2023
Q1 | $8.07M | Sell |
108,082
-168,596
| -61% | -$14.1M | 0.13% | 107 |
|
|
2022
Q4 | $19.4M | Buy |
276,678
+26,646
| +11% | +$2.57M | 0.17% | 105 |
|
|
2022
Q3 | $23.9M | Buy |
250,032
+164,061
| +191% | +$16.2M | 0.22% | 69 |
|
|
2022
Q2 | $7.97M | Buy |
85,971
+19,042
| +28% | +$1.86M | 0.18% | 79 |
|
|
2022
Q1 | $6.79M | Sell |
66,929
-471
| -0.7% | -$49.5K | 0.16% | 70 |
|
|
2021
Q4 | $6.95M | Buy |
67,400
+5,190
| +8% | +$480K | 0.17% | 67 |
|
|
2021
Q3 | $5.28M | Buy |
62,210
+9,037
| +17% | +$757K | 0.15% | 72 |
|
|
2021
Q2 | $4.44M | Buy |
53,173
+17,444
| +49% | +$1.43M | 0.13% | 82 |
|
|
2021
Q1 | $2.69M | Buy |
35,729
+10,002
| +39% | +$729K | 0.09% | 102 |
|
|
2020
Q4 | $1.76M | Buy |
25,727
+1,332
| +5% | +$86.6K | 0.07% | 94 |
|
|
2020
Q3 | $1.43M | Buy |
24,395
+1,398
| +6% | +$87K | 0.16% | 69 |
|
|
2020
Q2 | $1.5M | Sell |
22,997
-90
| -0.4% | -$5.67K | 0.18% | 62 |
|
|
2020
Q1 | $1.37M | Buy |
23,087
+134
| +0.6% | +$8.95K | 0.19% | 65 |
|
|
2019
Q4 | $17.1M | Buy |
22,953
+1,665
| +8% | +$117K | 0.19% | 56 |
|
|
2019
Q3 | $1.34M | Buy |
21,288
+109
| +0.5% | +$6.46K | 0.17% | 57 |
|
|
2019
Q2 | $1.15M | Buy |
21,179
+2,692
| +15% | +$145K | 0.14% | 73 |
|
|
2019
Q1 | $998K | Buy |
18,487
+7,408
| +67% | +$457K | 0.13% | 68 |
|
|
2018
Q4 | $726K | Buy |
+11,079
| New | +$827K | 0.21% | 40 |
|
|
2017
Q4 | – | Sell |
-100
| Closed | -$8K | – | 168 |
|
|
2017
Q3 | $8K | Sell |
100
-1,142
| -92% | -$90.3K | 0.01% | 148 |
|
|
2017
Q2 | $100K | Buy |
1,242
+954
| +331% | +$75.3K | 0.04% | 148 |
|
|
2017
Q1 | $23K | Buy |
+288
| New | +$23K | 0.01% | 230 |
|
|
2016
Q4 | – | Sell |
-160
| Closed | -$14K | – | 121 |
|
|
2016
Q3 | $14K | Sell |
160
-48
| -23% | -$4.53K | 0.01% | 111 |
|
|
2016
Q2 | $21K | Buy |
208
+100
| +93% | +$9.97K | 0.02% | 85 |
|
|
2016
Q1 | $11K | Buy |
+108
| New | +$10.5K | 0.02% | 100 |
|
|
2015
Q4 | – | Sell |
-100
| Closed | -$10K | – | 106 |
|
|
2015
Q3 | $10K | Buy |
+100
| New | +$10.5K | 0.03% | 84 |
|
|
2015
Q1 | – | Sell |
-406
| Closed | -$39K | – | 123 |
|
|
2014
Q4 | $39K | Sell |
406
-440
| -52% | -$38.8K | 0.13% | 39 |
|
|
2014
Q3 | $67K | Buy |
846
+440
| +108% | +$34.7K | 0.21% | 34 |
|
|
2014
Q2 | $31K | Hold |
406
| – | – | 0.09% | 42 |
|
|
2014
Q1 | $30K | Hold |
406
| – | – | 0.08% | 43 |
|
|
2013
Q4 | $29K | Sell |
406
-190
| -32% | -$12.2K | 0.06% | 83 |
|
|
2013
Q3 | $34K | Hold |
596
| – | – | 0.15% | 99 |
|
|
2013
Q2 | $34K | Buy |
+596
| New | +$34.5K | 0.04% | 150 |
|
Other funds holding CVS
Pathstone Family Office's CVS Position: Q3 2023 in Review
Pathstone Family Office increased its CVS Health (CVS) stake by 23% in Q3 2023, buying an estimated $1.88M and bringing the position to 141,150 shares worth $9.87M. The position accounts for 0.08% of the portfolio, ranked #174.
Pathstone Family Office first reported a position in CVS in Q2 2013 and has held it in 34 quarters since. The position peaked at $23.9M in Q3 2022. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Pathstone Family Office held 141,150 shares of CVS Health worth $9.87M as of Q3 2023.
- Pathstone Family Office bought 26,602 CVS Health shares in Q3 2023, an estimated $1.88M.
- CVS Health made up 0.08% of Pathstone Family Office's portfolio in Q3 2023, its #174 holding.
- Pathstone Family Office first reported a position in CVS Health in Q2 2013 and has held it in 34 quarters since.
- Pathstone Family Office's CVS Health position peaked at $23.9M in Q3 2022.
- 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.